HIV-1 gag proteins: diverse functions in the virus life cycle.
暂无分享,去创建一个
[1] D. Markovitz,et al. The role of mononuclear phagocytes in HTLV-III/LAV infection. , 1986, Science.
[2] R. Gorelick,et al. A leucine triplet repeat sequence (LXX)4 in p6gag is important for Vpr incorporation into human immunodeficiency virus type 1 particles , 1995, Journal of virology.
[3] B. Gay,et al. Phenotypic characterization of insertion mutants of the human immunodeficiency virus type 1 Gag precursor expressed in recombinant baculovirus-infected cells , 1994, Journal of virology.
[4] M. Bukrinsky,et al. Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[5] J. Wills,et al. Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the Gag p9 protein , 1997, Journal of virology.
[6] M. Emerman,et al. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells , 1993, Nature.
[7] J. Luban,et al. Specific incorporation of cyclophilin A into HIV-1 virions , 1994, Nature.
[8] F. Bushman,et al. HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase , 1995, Cell.
[9] Jeremy Luban,et al. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B , 1993, Cell.
[10] C. McHenry,et al. Human immunodeficiency virus nucleocapsid protein accelerates strand transfer of the terminally redundant sequences involved in reverse transcription. , 1994, The Journal of biological chemistry.
[11] J. Berg,et al. The Galvanization of Biology: A Growing Appreciation for the Roles of Zinc , 1996, Science.
[12] H. Varmus,et al. Retroviral Virions and Genomes -- Retroviruses , 1997 .
[13] W. Sundquist,et al. Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[14] C. Péchoux,et al. Mutations in the N-terminal domain of human immunodeficiency virus type 1 nucleocapsid protein affect virion core structure and proviral DNA synthesis , 1997, Journal of virology.
[15] H. Göttlinger,et al. A conserved LXXLF sequence is the major determinant in p6gag required for the incorporation of human immunodeficiency virus type 1 Vpr , 1996, Journal of virology.
[16] Z. Tsuchihashi,et al. Influence of Human Immunodeficiency Virus Nucleocapsid Protein on Synthesis and Strand Transfer by the Reverse Transcriptase in Vitro(*) , 1995, The Journal of Biological Chemistry.
[17] A. Gronenborn,et al. Identification of a binding site for the human immunodeficiency virus type 1 nucleocapsid protein. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[18] I. Jones,et al. Gag-Gag interactions in the C-terminal domain of human immunodeficiency virus type 1 p24 capsid antigen are essential for Gag particle assembly. , 1996, The Journal of general virology.
[19] P. Borer,et al. Structure of the HIV-1 nucleocapsid protein bound to the SL3 psi-RNA recognition element. , 1998, Science.
[20] J. Luban,et al. Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription , 1996, Journal of virology.
[21] J. Sodroski,et al. Functional association of cyclophilin A with HIV-1 virions , 1994, Nature.
[22] É. Cohen,et al. The Putative Alpha Helix 2 of Human Immunodeficiency Virus Type 1 Vpr Contains a Determinant Which Is Responsible for the Nuclear Translocation of Proviral DNA in Growth-Arrested Cells , 1998, Journal of Virology.
[23] Z. Matsuda,et al. The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions , 1992, Journal of virology.
[24] D Cowburn,et al. Solution structure and dynamics of the bioactive retroviral M domain from Rous sarcoma virus. , 1998, Journal of molecular biology.
[25] E. Barklis,et al. Nucleocapsid protein effects on the specificity of retrovirus RNA encapsidation , 1995, Journal of virology.
[26] S. S. Hong,et al. Functional domains of HIV-1 gag-polyprotein expressed in baculovirus-infected cells. , 1991, Virology.
[27] E. Barklis,et al. Effects of nucleocapsid mutations on human immunodeficiency virus assembly and RNA encapsidation , 1997, Journal of virology.
[28] T. Ruml,et al. The three‐dimensional solution structure of the matrix protein from the type D retrovirus, the Mason–Pfizer monkey virus, and implications for the morphology of retroviral assembly , 1997, The EMBO journal.
[29] S. Höglund,et al. Functional domains of the capsid protein of human immunodeficiency virus type 1 , 1994, Journal of virology.
[30] T. Hope,et al. HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[31] E. Freed,et al. Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production , 1994, Journal of virology.
[32] H. Zentgraf,et al. The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity , 1995, Journal of virology.
[33] A. Panganiban,et al. The human immunodeficiency virus type 1 encapsidation site is a multipartite RNA element composed of functional hairpin structures , 1996, Journal of virology.
[34] M. Emerman,et al. HIV-1 infection of non-dividing cells , 1994, Nature.
[35] J. Luban,et al. Specific binding of human immunodeficiency virus type 1 gag polyprotein and nucleocapsid protein to viral RNAs detected by RNA mobility shift assays , 1993, Journal of virology.
[36] R. Gorelick,et al. HIV-1 nucleocapsid protein induces "maturation" of dimeric retroviral RNA in vitro. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[37] J. Sodroski,et al. Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains , 1995, Journal of virology.
[38] L. Arthur,et al. Inhibitors of HIV Nucleocapsid Protein Zinc Fingers as Candidates for the Treatment of AIDS , 1995, Science.
[39] O. Haffar,et al. Characterization of human immunodeficiency virus type 1 Pr55gag membrane association in a cell-free system: requirement for a C-terminal domain. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[40] J. Domagala,et al. The in vitro ejection of zinc from human immunodeficiency virus (HIV) type 1 nucleocapsid protein by disulfide benzamides with cellular anti-HIV activity. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[41] W. Paxton,et al. Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis , 1993, Journal of virology.
[42] M. Summers,et al. The nucleocapsid protein isolated from HIV-1 particles binds zinc and forms retroviral-type zinc fingers. , 1990, Biochemistry.
[43] A. Kaplan,et al. The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions , 1994, Journal of virology.
[44] L. Ratner,et al. Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[45] D. Trono,et al. The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[46] K. Moelling,et al. Specific binding of HIV‐1 nucleocapsid protein to PSI RNA in vitro requires N‐terminal zinc finger and flanking basic amino acid residues. , 1994, The EMBO journal.
[47] S. Goff,et al. The role of Gag in human immunodeficiency virus type 1 virion morphogenesis and early steps of the viral life cycle , 1996, Journal of virology.
[48] M. Resh,et al. Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids , 1994, Journal of virology.
[49] J G Levin,et al. Human immunodeficiency virus type 1 nucleocapsid protein promotes efficient strand transfer and specific viral DNA synthesis by inhibiting TAR-dependent self-priming from minus-strand strong-stop DNA , 1997, Journal of virology.
[50] K. Moelling,et al. Mutations of basic amino acids of NCp7 of human immunodeficiency virus type 1 affect RNA binding in vitro , 1996, Journal of virology.
[51] H. Gelderblom,et al. Efficient HIV‐1 replication can occur in the absence of the viral matrix protein , 1998, The EMBO journal.
[52] D. Herschlag. RNA Chaperones and the RNA Folding Problem (*) , 1995, The Journal of Biological Chemistry.
[53] A. Burny,et al. The solution structure of the bovine leukaemia virus matrix protein and similarity with lentiviral matrix proteins. , 1996, The EMBO journal.
[54] X. Yu,et al. Identification and characterization of virus assembly intermediate complexes in HIV-1-infected CD4+ T cells. , 1998, Virology.
[55] J. Luban,et al. Binding of human immunodeficiency virus type 1 (HIV-1) RNA to recombinant HIV-1 gag polyprotein , 1991, Journal of virology.
[56] J. Luban,et al. Specificity and sequence requirements for interactions between various retroviral Gag proteins , 1994, Journal of virology.
[57] W. Haseltine,et al. Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein , 1994, Journal of virology.
[58] R. Wagner,et al. Identification of a region in the Pr55gag-polyprotein essential for HIV-1 particle formation. , 1993, Virology.
[59] Vm Vogt. Retroviral Virions and Genomes , 1997 .
[60] C. Sassetti,et al. RNA secondary structure and binding sites for gag gene products in the 5' packaging signal of human immunodeficiency virus type 1 , 1995, Journal of virology.
[61] John W. Mellors,et al. Human retroviruses and AIDS 1996. A compilation and analysis of nucleic acid and amino acid sequences , 1997 .
[62] M. Conte,et al. Retroviral matrix proteins: a structural perspective. , 1998, Virology.
[63] E. Tschachler,et al. Myristoylation of gag proteins of HIV-1 plays an important role in virus assembly. , 1990, AIDS research and human retroviruses.
[64] E. Hunter,et al. A single amino acid substitution within the matrix protein of a type D retrovirus converts its morphogenesis to that of a type C retrovirus , 1990, Cell.
[65] P. Dupraz,et al. Specificity of Rous sarcoma virus nucleocapsid protein in genomic RNA packaging , 1992, Journal of virology.
[66] M. Hammarskjöld,et al. Characterization of deletion mutations in the capsid region of human immunodeficiency virus type 1 that affect particle formation and Gag-Pol precursor incorporation , 1995, Journal of virology.
[67] R C Craven,et al. Form, function, and use of retroviral gag proteins. , 1991, AIDS.
[68] M. Resh,et al. Differential membrane binding of the human immunodeficiency virus type 1 matrix protein , 1996, Journal of virology.
[69] E. Sausville,et al. Inhibitors of human immunodeficiency virus type 1 zinc fingers prevent normal processing of gag precursors and result in the release of noninfectious virus particles , 1996, Journal of virology.
[70] N. Jullian,et al. Determination of the structure of the nucleocapsid protein NCp7 from the human immunodeficiency virus type 1 by 1H NMR. , 1992, The EMBO journal.
[71] É. Cohen,et al. The intracytoplasmic domain of gp41 mediates polarized budding of human immunodeficiency virus type 1 in MDCK cells , 1994, Journal of virology.
[72] B. Roques,et al. Viral RNA annealing activities of human immunodeficiency virus type 1 nucleocapsid protein require only peptide domains outside the zinc fingers. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[73] L. Ratner,et al. Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism , 1997, Journal of virology.
[74] E. Freed,et al. Role of Matrix in an Early Postentry Step in the Human Immunodeficiency Virus Type 1 Life Cycle , 1998, Journal of Virology.
[75] G. Rindi,et al. Influence of MA internal sequences, but not of the myristylated N-terminus sequence, on the budding site of HIV-1 Gag protein. , 1994, Biochemical and biophysical research communications.
[76] S. Goff,et al. Analysis of binding elements in the human immunodeficiency virus type 1 genomic RNA and nucleocapsid protein. , 1994, Virology.
[77] E. Freed,et al. Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions , 1996, Journal of virology.
[78] J. Darlix,et al. It is Rous sarcoma virus protein P12 and not P19 that binds tightly to Rous sarcoma virus RNA. , 1984, Journal of molecular biology.
[79] J. Luban,et al. Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release, and infectivity , 1995, Journal of virology.
[80] C. Cameron,et al. Fine mapping and characterization of the Rous sarcoma virus Pr76gag late assembly domain , 1996, Journal of virology.
[81] A. Smith,et al. Requirements for incorporation of Pr160gag-pol from human immunodeficiency virus type 1 into virus-like particles , 1993, Journal of virology.
[82] A. Panganiban,et al. Pleiotropic mutations in the HIV-1 matrix protein that affect diverse steps in replication. , 1997, Virology.
[83] E. Barklis,et al. Assembly, processing, and infectivity of human immunodeficiency virus type 1 gag mutants , 1993, Journal of virology.
[84] J. Mak,et al. Identification of tRNAs incorporated into wild-type and mutant human immunodeficiency virus type 1 , 1993, Journal of virology.
[85] W. Fu,et al. Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and protease-defective virions , 1994, Journal of virology.
[86] U. Geigenmüller,et al. Specific binding of human immunodeficiency virus type 1 (HIV-1) Gag-derived proteins to a 5' HIV-1 genomic RNA sequence , 1996, Journal of virology.
[87] M. Schwartz,et al. Distinct functions and requirements for the Cys-His boxes of the human immunodeficiency virus type 1 nucleocapsid protein during RNA encapsidation and replication , 1997, Journal of virology.
[88] E. Freed,et al. Phosphorylation of Residue 131 of HIV-1 Matrix Is Not Required for Macrophage Infection , 1997, Cell.
[89] P. Cosson. Direct interaction between the envelope and matrix proteins of HIV‐1. , 1996, The EMBO journal.
[90] C. Flexner,et al. Mutations of the Human Immunodeficiency Virus Type 1 p6Gag Domain Result in Reduced Retention of Pol Proteins during Virus Assembly , 1998, Journal of Virology.
[91] J. Sodroski,et al. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[92] P. Spearman,et al. The I Domain Is Required for Efficient Plasma Membrane Binding of Human Immunodeficiency Virus Type 1 Pr55Gag , 1998, Journal of Virology.
[93] C. Gabus,et al. The central globular domain of the nucleocapsid protein of human immunodeficiency virus type 1 is critical for virion structure and infectivity , 1995, Journal of virology.
[94] J. Luban,et al. Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein , 1993, Journal of virology.
[95] C. Cameron,et al. An assembly domain of the Rous sarcoma virus Gag protein required late in budding , 1994, Journal of virology.
[96] R. Shoeman,et al. A large deletion in the matrix domain of the human immunodeficiency virus gag gene redirects virus particle assembly from the plasma membrane to the endoplasmic reticulum , 1993, Journal of virology.
[97] R. Swanstrom,et al. Synthesis, Assembly, and Processing of Viral Proteins , 1997 .
[98] C. Gelfand,et al. Spectral analysis and tryptic susceptibility as probes of HIV-1 capsid protein structure. , 1994, Virology.
[99] M. Martin,et al. Incorporation of Pr160(gag-pol) into virus particles requires the presence of both the major homology region and adjacent C-terminal capsid sequences within the Gag-Pol polyprotein , 1997, Journal of virology.
[100] D. Trono,et al. HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator , 1995, Cell.
[101] H. Kräusslich,et al. Sequential Steps in Human Immunodeficiency Virus Particle Maturation Revealed by Alterations of Individual Gag Polyprotein Cleavage Sites , 1998, Journal of Virology.
[102] W. Sundquist,et al. Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. , 1997, Science.
[103] A. Aldovini,et al. Charged amino acid residues of human immunodeficiency virus type 1 nucleocapsid p7 protein involved in RNA packaging and infectivity , 1996, Journal of virology.
[104] M. Emerman,et al. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[105] J. Sodroski,et al. Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[106] H. Gendelman,et al. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. , 1986, Science.
[107] X. Yu,et al. Mutations in the N-terminal region of human immunodeficiency virus type 1 matrix protein block intracellular transport of the Gag precursor , 1993, Journal of virology.
[108] P. Brown,et al. DNA strand exchange and selective DNA annealing promoted by the human immunodeficiency virus type 1 nucleocapsid protein , 1994, Journal of virology.
[109] J. Wills,et al. Positionally independent and exchangeable late budding functions of the Rous sarcoma virus and human immunodeficiency virus Gag proteins , 1995, Journal of virology.
[110] C. Carter,et al. Assembly of recombinant human immunodeficiency virus type 1 capsid protein in vitro , 1992, Journal of virology.
[111] B. Roques,et al. First glimpses at structure-function relationships of the nucleocapsid protein of retroviruses. , 1995, Journal of molecular biology.
[112] W. Sundquist,et al. Three-dimensional structure of the HTLV-II matrix protein and comparative analysis of matrix proteins from the different classes of pathogenic human retroviruses. , 1996, Journal of molecular biology.
[113] M. Summers,et al. High-resolution structure of an HIV zinc fingerlike domain via a new NMR-based distance geometry approach. , 1990, Biochemistry.
[114] J. Luban,et al. Cyclosporine A-resistant human immunodeficiency virus type 1 mutants demonstrate that Gag encodes the functional target of cyclophilin A , 1996, Journal of virology.
[115] E. Barklis,et al. Analysis of the Assembly Function of the Human Immunodeficiency Virus Type 1 Gag Protein Nucleocapsid Domain , 1998, Journal of Virology.
[116] Nucleocapsid zinc fingers detected in retroviruses: EXAFS studies of intact viruses and the solution‐state structure of the nucleocapsid protein from HIV‐1 , 1992, Protein science : a publication of the Protein Society.
[117] F. Barré-Sinoussi,et al. Cis elements and trans-acting factors involved in the RNA dimerization of the human immunodeficiency virus HIV-1. , 1990, Journal of molecular biology.
[118] E. Freed,et al. Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection , 1995, Journal of virology.
[119] F. Bushman,et al. Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition , 1997, Journal of virology.
[120] D. Stuart,et al. Crystal structure of SIV matrix antigen and implications for virus assembly , 1995, Nature.
[121] E. Hunter. Macromolecular interactions in the assembly of HIV and other retroviruses , 1994 .
[122] M. Sudol,et al. WW domains and retrovirus budding , 1996, Nature.
[123] M. Wainberg,et al. Human immunodeficiency virus Type 1 nucleocapsid protein (NCp7) directs specific initiation of minus-strand DNA synthesis primed by human tRNA(Lys3) in vitro: studies of viral RNA molecules mutated in regions that flank the primer binding site , 1996, Journal of virology.
[124] M. Schwartz,et al. HIV-1 particle release mediated by Vpu is distinct from that mediated by p6. , 1996, Virology.
[125] E. Freed,et al. Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix , 1995, Journal of virology.
[126] E. Freed,et al. p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease , 1995, Journal of virology.
[127] M. Summers,et al. Inhibition of HIV-1 infectivity by zinc-ejecting aromatic C-nitroso compounds , 1993, Nature.
[128] W. Sundquist,et al. Three-dimensional structure of the human immunodeficiency virus type 1 matrix protein. , 1994, Journal of molecular biology.
[129] Zinc‐ and sequence‐dependent binding to nucleic acids by the N‐terminal zinc finger of the HIV‐1 nucleocapsid protein: NMR structure of the complex with the Psi‐site analog, dACGCC , 1993, Protein science : a publication of the Protein Society.
[130] Wesley I. Sundquist,et al. Structure of the Amino-Terminal Core Domain of the HIV-1 Capsid Protein , 1996, Science.
[131] J. Wills,et al. Functional chimeras of the Rous sarcoma virus and human immunodeficiency virus gag proteins , 1993, Journal of virology.
[132] L. Arthur,et al. Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA , 1990, Journal of virology.
[133] V. Vogt,et al. Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1 , 1995, Journal of virology.
[134] H. Kräusslich,et al. N-Terminal Extension of Human Immunodeficiency Virus Capsid Protein Converts the In Vitro Assembly Phenotype from Tubular to Spherical Particles , 1998, Journal of Virology.
[135] R. Young,et al. Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus , 1990, Journal of virology.
[136] I. Jones,et al. Distinct signals in human immunodeficiency virus type 1 Pr55 necessary for RNA binding and particle formation. , 1992, The Journal of general virology.
[137] M. Wainberg,et al. Effect of mutations in the nucleocapsid protein (NCp7) upon Pr160(gag-pol) and tRNA(Lys) incorporation into human immunodeficiency virus type 1 , 1997, Journal of virology.
[138] S. Höglund,et al. Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis , 1994, Journal of virology.
[139] W. Phares,et al. Spontaneous mutations in the human immunodeficiency virus type 1 gag gene that affect viral replication in the presence of cyclosporins , 1996, Journal of virology.
[140] Interactions between HIV-1 nucleocapsid protein and viral DNA may have important functions in the viral life cycle. , 1993, Nucleic acids research.
[141] W. Sundquist,et al. Crystal Structure of Human Cyclophilin A Bound to the Amino-Terminal Domain of HIV-1 Capsid , 1996, Cell.
[142] B. Wolff,et al. Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): interference with early and late events in HIV-1 replication , 1995, Journal of virology.
[143] S. S. Hong,et al. Assembly-defective point mutants of the human immunodeficiency virus type 1 Gag precursor phenotypically expressed in recombinant baculovirus-infected cells , 1993, Journal of virology.
[144] S. Modrow,et al. Inhibition of human immunodeficiency virus type 1 particle formation by alterations of defined amino acids within the C terminus of the capsid protein. , 1997, The Journal of general virology.
[145] O. Schwartz,et al. Cytosolic Gag p24 as an Index of Productive Entry of Human Immunodeficiency Virus Type 1 , 1998, Journal of Virology.
[146] E. Freed,et al. The Role of Human Immunodeficiency Virus Type 1 Envelope Glycoproteins in Virus Infection (*) , 1995, The Journal of Biological Chemistry.
[147] E. Barklis,et al. Assembly of gag-beta-galactosidase proteins into retrovirus particles , 1990, Journal of virology.
[148] A. Aderem,et al. The myristoyl-electrostatic switch: a modulator of reversible protein-membrane interactions. , 1995, Trends in biochemical sciences.
[149] L. Arthur,et al. Genetic analysis of the zinc finger in the Moloney murine leukemia virus nucleocapsid domain: replacement of zinc-coordinating residues with other zinc-coordinating residues yields noninfectious particles containing genomic RNA , 1996, Journal of virology.
[150] E. Freed,et al. Characterization of human immunodeficiency virus type 1 matrix revertants: effects on virus assembly, Gag processing, and Env incorporation into virions , 1997, Journal of virology.
[151] W. Alvord,et al. Inhibition of Friend virus replication by a compound that reacts with the nucleocapsid zinc finger: anti-retroviral effect demonstrated in vivo. , 1998, Virology.
[152] R. Flügel,et al. Analysis of the primary structure of the long terminal repeat and the gag and pol genes of the human spumaretrovirus , 1988, Journal of virology.
[153] M. Malim,et al. HIV‐1 infection of non‐dividing cells: evidence that the amino‐terminal basic region of the viral matrix protein is important for Gag processing but not for post‐entry nuclear import , 1997, The EMBO journal.
[154] Z. Matsuda,et al. Role of the C terminus Gag protein in human immunodeficiency virus type 1 virion assembly and maturation. , 1995, The Journal of general virology.
[155] M. Summers,et al. The nucleocapsid protein isolated for HIV-1 particles binds zinc and forms retroviral-type zinc fingers. , 1990, Disease markers.
[156] E. Barklis,et al. Conditional infectivity of a human immunodeficiency virus matrix domain deletion mutant , 1993, Journal of virology.
[157] Qian-chun Yu,et al. The C terminus of human immunodeficiency virus type 1 matrix protein is involved in early steps of the virus life cycle , 1992, Journal of virology.
[158] M. Wainberg,et al. Role of Pr160gag-pol in mediating the selective incorporation of tRNA(Lys) into human immunodeficiency virus type 1 particles , 1994, Journal of virology.
[159] H. Issaq,et al. Tightly bound zinc in human immunodeficiency virus type 1, human T-cell leukemia virus type I, and other retroviruses , 1992, Journal of virology.
[160] Carol Carter,et al. Crystal structure of dimeric HIV-1 capsid protein , 1996, Nature Structural Biology.
[161] S. Balasubramanian,et al. Recombinant HIV-1 nucleocapsid protein accelerates HIV-1 reverse transcriptase catalyzed DNA strand transfer reactions and modulates RNase H activity. , 1994, Biochemistry.
[162] T. Sata,et al. Role of the gag and pol genes of human immunodeficiency virus in the morphogenesis and maturation of retrovirus-like particles expressed by recombinant vaccinia virus: an ultrastructural study. , 1991, The Journal of general virology.
[163] T. Smithgall,et al. Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[164] W. Sundquist,et al. Proteolytic refolding of the HIV‐1 capsid protein amino‐terminus facilitates viral core assembly , 1998, The EMBO journal.
[165] E. Jacobs,et al. Assembly and release of HIV-1 precursor Pr55 gag virus-like particles from recombinant baculovirus-infected insect cells , 1989, Cell.
[166] S. Goff,et al. Retroviral nucleocapsid domains mediate the specific recognition of genomic viral RNAs by chimeric Gag polyproteins during RNA packaging in vivo , 1995, Journal of virology.